ARDX - Ardelyx, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ARDX (1437402)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
78 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P43+3+7+2+2
S35-1-1-5-33

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-03-10
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$13.48-1,000121,049-1%-$13,482+2+6
2017-03-03
ARDXCaldwell Jeremy SEVP, Chief Scientific OfficerS - Sale$14.14-1,02617,985-5%-$14,512-3-5
D
2017-03-01
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$13.70-3,00068,450-4%-$41,100-3-5
D
2017-02-01
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$12.00-3,00067,510-4%-$36,000-1+3+24
2017-01-05
ARDXKorner PaulEVP, Chief Medical OfficerS - Sale$12.95-6,13054,623-10%-$79,3840-30
2016-12-16
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$14.48-900100,372-1%-$13,035-6+1-7
2016-11-11
ARDXCaldwell Jeremy SEVP, Chief Scientific OfficerS - Sale$15.13-2,1580-100%-$32,646-2+1-4
D
2016-10-11
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$15.00-6,00049,525-11%-$90,000-6-2+6
DM
2016-09-22
ARDXGrammer Elizabeth ASVP, GCS - Sale+OE$12.00-5,0000-100%-$60,000+6+5+13
D
2016-09-19
ARDXGrammer Elizabeth ASVP, GCS - Sale+OE$11.21-6,8590-100%-$76,880-1+9+12+19
2016-07-18
ARDXWeller Harry R10%P - Purchase$8.73+1,527,3015,331,631+40%+$13,333,338+6+8+4
2016-07-18
ARDXViswanathan Ravi10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-07-18
ARDXSonsini Peter W.10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-07-18
ARDXSandell Scott D10%P - Purchase$8.73+2,290,95114,084,174+19%+$20,000,002+6+8+4
2016-07-18
ARDXSakoda Jon10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-07-18
ARDXMott David MDir, 10%P - Purchase$8.73+1,527,3015,345,382+40%+$13,333,338+6+8+4
2016-07-18
ARDXMakower Joshua10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-07-18
ARDXKolluri Krishna Kittu10%P - Purchase$8.73+2,290,95114,083,582+19%+$20,000,002+6+8+4
2016-07-18
ARDXKerins Patrick J10%P - Purchase$8.73+763,6508,752,784+10%+$6,666,665+6+8+4
2016-07-18
ARDXFlorence Anthony A. Jr.10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-07-18
ARDXBaskett Forest10%P - Purchase$8.73+2,290,95114,084,067+19%+$20,000,002+6+8+4
2016-07-18
ARDXBarris Peter J10%P - Purchase$8.73+2,290,95114,084,162+19%+$20,000,002+6+8+4
2016-07-18
ARDXBarrett M James10%P - Purchase$8.73+763,6508,752,543+10%+$6,666,665+6+8+4
2016-07-18
ARDXNew Enterprise Associates 12, Limited Partnership10%P - Purchase$8.73+763,6508,752,543+10%+$6,666,665+6+8+4
2016-07-18
ARDXNea 15 Gp, LLC10%P - Purchase$8.73+1,527,3015,331,039+40%+$13,333,338+6+8+4
2016-03-21
ARDXRingold GordonDirP - Purchase$7.77+15,00025,000+150%+$116,540+5-6+9+52
2016-03-03
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$10.74-1,128101,272-1%-$12,110-11-15-23+8
AM
2015-09-21
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$22.05-1,40099,532-1%-$30,874-11-15-23+8
A
2015-09-15
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$22.01-2,540100,932-2%-$55,898-11-15-23+8
D
2016-02-16
ARDXKaufmann MarkCFOS - Sale+OE$10.25-5,0001,282-80%-$51,272+4-3-32-1
2016-01-13
ARDXSakoda Jon10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+12+1-5
2016-01-13
ARDXWeller Harry R10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2016-01-13
ARDXViswanathan Ravi10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2016-01-13
ARDXSonsini Peter W.10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2016-01-13
ARDXSandell Scott D10%P - Purchase$10.00+1,500,00011,793,223+15%+$15,000,0000+3-3-18
2016-01-13
ARDXMott David MDir, 10%P - Purchase$10.00+1,000,0003,809,559+36%+$10,000,0000+3-3-18
2016-01-13
ARDXMakower Joshua10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2016-01-13
ARDXKolluri Krishna Kittu10%P - Purchase$10.00+1,500,00011,792,631+15%+$15,000,0000+3-3-18
2016-01-13
ARDXKerins Patrick J10%P - Purchase$10.00+500,0007,989,134+7%+$5,000,0000+3-3-18
2016-01-13
ARDXFlorence Anthony A. Jr.10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2016-01-13
ARDXBaskett Forest10%P - Purchase$10.00+1,500,00011,793,116+15%+$15,000,0000+3-3-18
2016-01-13
ARDXBarris Peter J10%P - Purchase$10.00+1,500,00011,793,211+15%+$15,000,0000+3-3-18
2016-01-13
ARDXBarrett M James10%P - Purchase$10.00+500,0007,988,893+7%+$5,000,0000+3-3-18
2016-01-13
ARDXNew Enterprise Associates 12, Limited Partnership10%P - Purchase$10.00+500,0007,988,893+7%+$5,000,0000+3-3-18
2016-01-13
ARDXNea 15 Gp, LLC10%P - Purchase$10.00+1,000,0003,803,738+36%+$10,000,0000+3-3-18
2015-12-17
ARDXBertrand William C JrDirP - Purchase$20.00+5,0005,000New+$100,000-6-6-47-60
D
2015-12-15
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$20.00-2,00047,420-4%-$40,000+1-3-44-57
D
2015-11-27
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$20.00-2,00047,420-4%-$40,000+1-12-5-57
D
2015-10-08
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$19.88-2,00047,420-4%-$39,760-7-4-4-59
M
2015-09-21
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$22.05-1,400173,784-1%-$30,874+2-22-19-66
2015-09-15
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$22.01-2,540100,932-2%-$55,898+2-1-10-70
D
2015-09-10
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$20.59-2,00047,420-4%-$41,185+2+3-1-61
2015-09-08
ARDXRaab MichaelPres, CEOS - Sale$20.29-9,78571,903-12%-$198,544+1+1-3-64
M
2015-09-01
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$18.78-2,537103,472-2%-$47,641+2+110-49
2015-09-01
ARDXCaldwell Jeremy SEVP, Chief Scientific OfficerS - Sale$18.32-6430-100%-$11,780+2+110-49
2015-09-01
ARDXGrammer Elizabeth AVP, GCS - Sale$18.32-8930-100%-$16,360+2+110-49
A
2015-07-30
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$19.27-2,011103,472-2%-$38,755-3+4-13-49
2015-08-18
ARDXRaab MichaelPres, CEOS - Sale$20.00-1,10480,170-1%-$22,080+6+9+14-43
D
2015-08-06
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$19.07-2,00046,666-4%-$38,140+3+4+10-49
2015-08-03
ARDXRaab MichaelPres, CEOS - Sale$20.00-30081,2740%-$6,000-3-8-5-50
2015-07-30
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$19.27-2,011109,792-2%-$38,7550-8-5-47
2015-07-28
ARDXRaab MichaelPres, CEOS - Sale$20.00-2,11181,574-3%-$42,220+4+2-6-46
D
2015-07-28
ARDXJacobs Jeffrey WSVP, Technical OpsS - Sale+OE$20.00-2,50046,666-5%-$50,000-2+3-8-45
D
2015-07-22
ARDXGrammer Elizabeth AVP, GCS - Sale+OE$18.00-2,5000-100%-$45,000-1+6-4-41
D
2015-07-15
ARDXGrammer Elizabeth AVP, GCS - Sale+OE$17.11-10,0000-100%-$171,1500+7+7-42
D
2015-06-10
ARDXRingold GordonDirP - Purchase$15.19+10,00010,000New+$151,880+16+12+18+21
D
2015-06-05
ARDXBarris Peter J10%P - Purchase$10.70+4,672,89710,293,211+83%+$49,999,998+3+16+9+30
D
2015-06-05
ARDXBarrett M James10%P - Purchase$10.70+1,869,1597,488,893+33%+$20,000,001+3+16+9+30
D
2015-06-05
ARDXBaskett Forest10%P - Purchase$10.70+4,672,89710,293,116+83%+$49,999,998+3+16+9+30
D
2015-06-05
ARDXDrant Ryan D10%P - Purchase$10.70+1,869,1597,489,485+33%+$20,000,001+3+16+9+30
D
2015-06-05
ARDXKerins Patrick J10%P - Purchase$10.70+1,869,1597,489,134+33%+$20,000,001+3+16+9+30
D
2015-06-05
ARDXSandell Scott D10%P - Purchase$10.70+4,672,89710,293,223+83%+$49,999,998+3+16+9+30
D
2015-06-05
ARDXKolluri Krishna Kittu10%P - Purchase$10.70+4,672,89710,292,631+83%+$49,999,998+3+16+9+30
D
2015-06-05
ARDXMott David MDir, 10%P - Purchase$10.70+2,803,7382,803,738New+$29,999,997+3+16+9+30
D
2015-06-05
ARDXNew Enterprise Associates 12, Limited Partnership10%P - Purchase$10.70+1,869,1597,488,893+33%+$20,000,001+3+16+9+30
D
2015-06-05
ARDXSchultz Peter GDirP - Purchase$10.70+46,729907,429+5%+$500,00000+14+30
D
2015-05-04
ARDXKaufmann MarkCFOS - Sale+OE$10.81-9,083596-94%-$98,232-24-17+37+50
D
2015-04-06
ARDXKaufmann MarkCFOS - Sale+OE$12.80-7,681596-93%-$98,331+4+6-33+50

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top